Ep Wealth Advisors, LLC Amgen Inc Transaction History

Ep Wealth Advisors, LLC

$9.28 Billion
Q2 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 29,828 shares of AMGN stock, worth $9.55 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

29,828

Previous 23,769 25.49%

Holding current value

$9.55 Million

Previous $6.76 Million 37.9%

% of portfolio

0.1%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	BUY	$262.75 - $319.31 $1.59 Million - $1.93 Million	6,059 Added 25.49%	29,828 $9.32 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $632,651 - $763,689	2,353 Added 10.99%	23,769 $6.76 Million
Q4 2023 Feb 28, 2024	SELL	$255.7 - $288.46 $638,227 - $719,996	-2,496 Reduced 10.44%	21,416 $6.17 Million
Q3 2023 Nov 22, 2023	BUY	$218.65 - $271.46 $862,355 - $1.07 Million	3,944 Added 19.75%	23,912 $6.43 Million
Q1 2023 Jun 05, 2023	SELL	$225.79 - $275.2 $1.99 Million - $2.42 Million	-8,807 Reduced 30.61%	19,968 $4.83 Million
Q4 2022 Jun 12, 2023	BUY	$229.03 - $291.01 $1.68 Million - $2.13 Million	7,316 Added 36.64%	27,284 $7.17 Million
Q3 2022 Dec 02, 2022	BUY	$224.46 - $253.15 $1.83 Million - $2.07 Million	8,170 Added 39.65%	28,775 $6.49 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $16,841 - $18,742	73 Added 0.36%	20,605 $5.01 Million
Q1 2022 May 20, 2022	SELL	$219.27 - $242.57 $37,275 - $41,236	-170 Reduced 0.82%	20,532 $4.97 Million
Q4 2021 Feb 17, 2022	BUY	$198.88 - $227.6 $150,751 - $172,520	758 Added 3.8%	20,702 $4.66 Million
Q3 2021 Nov 23, 2021	BUY	$212.27 - $248.7 $3.91 Million - $4.58 Million	18,416 Added 1205.24%	19,944 $4.24 Million
Q3 2021 Nov 16, 2021	SELL	$212.27 - $248.7 $3.84 Million - $4.5 Million	-18,103 Reduced 92.22%	1,528 $4.24 Million
Q2 2021 Aug 24, 2021	SELL	$233.58 - $259.14 $148,790 - $165,072	-637 Reduced 3.14%	19,631 $4.79 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $185,294 - $215,931	-835 Reduced 3.96%	20,268 $5.04 Million
Q4 2020 Feb 18, 2021	BUY	$216.38 - $257.67 $115,330 - $137,338	533 Added 2.59%	21,103 $4.85 Million
Q3 2020 Nov 17, 2020	SELL	$234.65 - $260.95 $427,297 - $475,189	-1,821 Reduced 8.13%	20,570 $5.23 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $807,262 - $990,621	4,081 Added 22.29%	22,391 $5.28 Million
Q1 2020 May 18, 2020	BUY	$182.24 - $241.7 $547,813 - $726,550	3,006 Added 19.64%	18,310 $3.71 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $434,426 - $558,387	2,296 Added 17.65%	15,304 $3.69 Million
Q3 2019 Nov 18, 2019	BUY	$174.11 - $208.62 $2.26 Million - $2.71 Million	13,008 New	13,008 $2.52 Million
Q2 2019 Aug 27, 2019	SELL	$166.7 - $195.41 $2.27 Million - $2.66 Million	-13,598 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$180.87 - $203.88 $180,508 - $203,472	998 Added 7.92%	13,598 $2.58 Million
Q4 2018 Feb 19, 2019	BUY	$178.4 - $208.25 $262,248 - $306,127	1,470 Added 13.21%	12,600 $2.45 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $1.01 Million - $1.14 Million	5,467 Added 96.54%	11,130 $2.31 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $126,031 - $141,561	-759 Reduced 11.82%	5,663 $1.05 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $69,974 - $81,774	413 Added 6.87%	6,422 $1.1 Million
Q4 2017 Feb 15, 2018	SELL	$168.79 - $188.59 $9.44 Million - $10.5 Million	-55,907 Reduced 90.29%	6,009 $1.05 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $420,734 - $480,365	2,515 Added 4.23%	61,916 $11.5 Million
Q2 2017 Aug 17, 2017	BUY	N/A	59,401	59,401 $10.2 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Amgen Inc Transaction History